1[1]Yuste R, Sur M. Development and plasticity of the cerebral cortex: from molecules to maps. J Neurobiol, 1999,41:1~6.
2[2]Carter CA. Protein kinase C as a drug target: implications for drug or diet prevention and treatment of cancer. Curr Drug Targets,2000,1:163 ~ 183.
3[3]Mundy WR, Sutton LD. Characterization of a selective protein kinase C substrate derived from the MARCKS phosphorylation site domain for use in brain tissue homogenates. Anal Biochem,2000,278:185 ~ 191.
4[4]Mahadev K, Vemuri MC. Selective changes in protein kinase C isoforms and phosphorylation of endogenous substrate proteins in rat cerebral cortex during pre-and postnatal ethanol exposure.Arc of Biothem Bioph, 1998,356:249 ~ 257.
5[5]Weeber EJ, Atkins CM, Selcher JC, et al. A role for the beta isoform of protein kinase C in fear conditioning. J Neurosci,2000,20:5906~5914.
6[6]Naik MU, Benedikz E, Hernandez I, et al. Distribution of protein kinase Mzeta and the complete protein kinase C isoform family in rat brain. J Comp Neurol,2000,426:243 ~ 258.
7[7]Liu WS, Heckman CA. The sevenfold way of PKC regulation.Cell Signal, 1998,10:529~542.
8[8]Paratcha G, Furman M, Bevilaqua L, et al. Involvement of hippocampal PKCbeta Ⅰ isoform in the early phase of memory formation of an inhibitory avoidance learning. Brain Res,2000,855:199~205.
9[9]Harris AS, Denovan-Wright EM, Hamilton LC, et al. Protein kinase C beta Ⅱ mRNA levels decrease in the striatum and cortex of transgenic Huntington' s disease mice. J Psychiatry Neurosci,2001,26: 117~122.
10[10]Weeber EJ, Atkins CM, Selcher JC, et al. A role for the beta isoform of protein kinase C in fear conditioning. J Neurosci,2000,20:5906 ~ 5914.